Fate Therapeutics, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for FATE, updated each market day.
FATE AI Sentiment
AI predicts Fate Therapeutics, Inc. stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Fate Therapeutics, Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Sector
Exchange
Market Cap
$147,654,592
Cap Tier
Employees
161
Headquarters
SAN DIEGO, CA
Listed Since
Oct. 1, 2013
Website
FATE Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
FATE Volatility
Fate Therapeutics, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
